Jiangsu Apon Medical Technology Co Ltd Class A (300753) — Tangible Net Worth Ratio
Jiangsu Apon Medical Technology Co Ltd Class A (300753) has a Tangible Net Worth Ratio of 94.9% as of September 2025. This metric is calculated by deducting intangible assets (CN¥34.71 Million) from net assets (CN¥686.08 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See working capital to net assets of Jiangsu Apon Medical Technology Co Ltd C to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Jiangsu Apon Medical Technology Co Ltd Class A Tangible Net Worth Ratio (2014–2024)
This chart shows how Jiangsu Apon Medical Technology Co Ltd Class A's Tangible Net Worth Ratio has changed across 11 annual periods from 2014 to 2024. As of September 2025, the ratio stands at 94.9%, reflecting net assets of CN¥686.08 Million with intangible assets of CN¥34.71 Million CNY. See 300753 days of operational coverage to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for Jiangsu Apon Medical Technology Co Ltd Class A (2014–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for Jiangsu Apon Medical Technology Co Ltd Class A from 2014 to 2024, covering 11 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see Jiangsu Apon Medical Technology Co Ltd C stock valuation.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 94.9% | CN¥707.86 Million | CN¥36.30 Million | CN¥863.49 Million | ▼ -0.2 pp |
| 2023 | 95.1% | CN¥697.20 Million | CN¥34.02 Million | CN¥859.57 Million | ▲ +0.3 pp |
| 2022 | 94.8% | CN¥686.36 Million | CN¥35.58 Million | CN¥870.21 Million | ▼ -0.9 pp |
| 2021 | 95.7% | CN¥780.52 Million | CN¥33.24 Million | CN¥899.06 Million | ▲ +0.8 pp |
| 2020 | 94.9% | CN¥739.84 Million | CN¥37.67 Million | CN¥827.24 Million | ▲ +1.3 pp |
| 2019 | 93.6% | CN¥674.88 Million | CN¥43.05 Million | CN¥757.64 Million | ▼ -1.1 pp |
| 2018 | 94.7% | CN¥613.39 Million | CN¥32.48 Million | CN¥687.96 Million | ▲ +8.1 pp |
| 2017 | 86.6% | CN¥279.38 Million | CN¥37.52 Million | CN¥333.26 Million | ▲ +0.7 pp |
| 2016 | 85.9% | CN¥229.59 Million | CN¥32.49 Million | CN¥294.51 Million | ▼ -12.7 pp |
| 2015 | 98.6% | CN¥145.40 Million | CN¥2.05 Million | CN¥180.28 Million | ▲ +1.2 pp |
| 2014 | 97.4% | CN¥81.37 Million | CN¥2.10 Million | CN¥115.80 Million | — |